In addition, I note that Regeneus is giving a presentation at a Pharma manufacturer conference in South Korea in April. Could this mean RGS is looking for a another JV/licensing deal, this time in South Korea?
You would think RGS would have confidence in the Progenza STEP trial results to be doing this. We will be finding out soon enough!
(Korean)
http://www.kpbma.or.kr/sub/select/00000000034/00000000040/239552
Beaufort Securities - UK Broker Alert, page-5
Add CMB (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
0.4¢ |
Change
0.000(0.00%) |
Mkt cap ! $4.772M | |||
| Open | High | Low | Value | Volume |
| 0.0¢ | 0.0¢ | 0.0¢ | $0 | 0 |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 7 | 1267251 | 0.4¢ |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| 0.6¢ | 746300 | 6 |
View Market Depth
| Last trade - 16.12pm 03/07/2024 (20 minute delay) ? |
| CMB (ASX) Chart |
Day chart unavailable